Skip to main content
TRVI logo

TRVI · Trevi Therapeutics, Inc. · Holdings

Track TRVI — free
$13.35 -0.37 (-2.70%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$1.90B
Shares
142.56M
Volume · Nov 20 2.09M Avg daily vol (3M) 1.99M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 226
Total Value: $2,165,579,664
Total Shares: 151,227,640
Showing 1–100 of 233 holdings by value · page 1 of 3

Institutional Ownership Trend

27 quarters

Holder Concentration

Share of 13F common-share value, across 226 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
9.0%
Dec 2023 → Sep 2026 · range 8.9% – 22.1%
+0.1 pts
Top 5
36.3%
Dec 2023 → Sep 2026 · range 34.6% – 62.3%
+1.0 pts
Top 10
49.7%
Dec 2023 → Sep 2026 · range 49.3% – 83.4%
+0.5 pts
HHI
368
Dec 2023 → Sep 2026 · range 361 – 1,038
Broadly held+6

Who Holds TRVI

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 223 filers, like-for-like change +1.5%; actively managed books +0.4%; index-like books +5.7%.

Holder type Share Filers Change
Registered adviser 50.3% 111 -8.1%
Exempt adviser 4.1% 6 +20.4%
Adviser 4.7% 8 +44.3%
Bank 5.0% 14 -3.1%
Insurer 0.0% 2 +69.5%
Broker-dealer 0.0% 1 -28.6%
Benefit plan 0.2% 5 +41.5%
Non-US 0.2% 8 +8.8%
Holding company 22.1% 9 +6.1%
Unknown 13.2% 59 +26.9%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 2 holders with no observed 2026-06-30 13F and 3 holders with no observed 2026-09-30 13F.

Conviction and Crowding

223 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
11
4.93% of filers hold it in their top 10
Jun 30, 2026: 12
Holders above 5%
6
median weight 0.003%
Jun 30, 2026: 8
Crowding
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Top 10 holders
49.7%
of 13F shares, Herfindahl 0.037
Active holders
+0.4%
like-for-like share change of active filers
5% stakes on record
4
1 13D, 3 13G (2 institutional, 1 passive, 0 exempt)
How long holders have held it value-weighted 10.6 quarters
Under 1 year 18.6% 1 to 3 years 47.5% 3 years or more 33.8% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $38,184,837 (9 buying, 13 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$9.96
estimated per share
Jun 30, 2026: $8.66
Quarter-end price
$14.32
implied by 13F values
Estimated gain or loss
+43.7%
price against the estimated cost
Estimated at a loss
21.3%
of costed 13F value

Estimated cost covers 70.5% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies TRVI's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 ERAS Erasca, Inc. 15
2 DYN Dyne Therapeutics, Inc. 15
3 IRON Disc Medicine, Inc. 13
4 TNGX Tango Therapeutics, Inc. 15
5 SVRA Savara Inc 12
6 EWTX Edgewise Therapeutics, Inc. 13
7 MBX MBX Biosciences, Inc. 11
8 ABVX Abivax S.A. 19
9 DNTH Dianthus Therapeutics, Inc. 12
10 SYRE Spyre Therapeutics, Inc. 12

Shareholder Targets

13F filers that own its peers but not TRVI, quarter ended Sep 30, 2026

Found through its holder-overlap peers: ERAS, DYN, IRON, TNGX, SVRA, EWTX, MBX, ABVX, DNTH, SYRE, ORIC, COGT, ACRS, PRAX, PVLA, ORKA, ELVN, ATTO, TRAX, CLYM. 624 filers in all.

# Filer In peers
1 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $1,765,110,699 6 held
2 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $1,574,539,015 7 held
3 RTW INVESTMENTS, LP Registered adviser, Diversified active $1,405,610,881 10 held
4 TCG Crossover Management, LLC Unknown, Diversified active $1,295,276,903 10 held
5 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $1,255,214,774 8 held
6 Venrock Adviser, LLC Registered adviser, Concentrated $1,161,933,229 8 held
7 Polar Capital Holdings Plc Registered adviser, Diversified active $1,113,460,969 11 held
8 ADAGE CAPITAL PARTNERS GP, L.L.C. Registered adviser, Diversified active $961,077,560 15 held
9 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $915,730,738 6 held
10 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $838,471,217 8 held

Fund Ownership of TRVI by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.55% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.51% 3,584,962
Index ETFs 9.04% 12,884,134
Active ETFs 0.19% 265,182
Active funds 13.53% 19,292,393
Unclassified 0.16% 231,602
All registered funds 25.43% 36,258,273
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
35
Increased
86
Decreased
57
Sold Out
29
Unchanged
46

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +5
Institutional value: -22.1%
Shares held: +1.5%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 233
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 233 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1563880 CUSIP 89532M101 13F (30d) 224 filings 210 filers Visit website Investor relations